We are international
Donate
TEXT SIZE   

Call the IMF Hotline. We are here for you. The IMF Office is open from 8:00AM - 5:00PM PST, Monday-Friday.

If you have a question, call the IMF InfoLine at (800) 452-CURE (800-452-2873) in the US and Canada. The InfoLine is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
    next      view all

The Tweets Have Been Tallied and We Want to Say Thanks!
Thank you to the many IMF social media followers who participated in the #DiscoverMyeloma campaign on Twitter, and of course, a big thanks to everyone at Takeda for their generous $30,000 donation! Takeda Oncology, a division of Takeda Pharmaceutical Company, ran a social media fundraising and awareness drive in March during Myeloma Awareness month, pledging $5 to the IMF for every tweet sent using the hashtag #DiscoverMyeloma. Well, the Tweets have been counted and there were 6,000 tweets (!) spreading the word, facts and resources about the fight against myeloma! “We’re so grateful to all for their daily participation and help in driving further awareness about myeloma with the larger community,” said Robin Tuohy, Senior Director of Support Groups for the IMF. “Now thanks to the combined efforts of each individual and the generosity of Takeda, the IMF has a wonderful donation to help us continue our mission to find a cure.”

Myeloma Immune Therapy Emerges as a Key Theme at ASCO 2015
In his blog this week, IMF Chairman Dr. Brian Durie reviews abstracts of the top myeloma studies to be presented at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO). “Immune therapy in myeloma will likely dominate the news,” writes Dr. Durie of the event, which begins May 29th in Chicago. Click HERE to read his blog.

The IMF's Concise Review Has Been Revised!
The IMF is pleased to announce that we’ve published an updated version of our Concise Review of the Disease and Treatment Options for myeloma patients! The Concise Review is an overview of myeloma, with a discussion of pathophysiology, clinical features, and treatment options to help you better understand a diagnosis. The IMF serves myeloma patients and family members and provides a wide range of programs in the areas of research, education, support, and advocacy. To download the pdf, please click HERE.

Dr. Durie's Blog: Life Extension? No, Let's Shoot for Permanent Remission
In the two weeks since we lost one of our most beloved patients, Mike Katz, our inability to cure myeloma has been staring us in the face. While the extended lives of myeloma patients is something to be celebrated, we need decisively better drugs to achieve our goal of permanent remission. How do we set the bar high enough to achieve these great outcomes?

Living Well with Myeloma: Sustainable Wellness – An Integrative Approach to Transform Your Mind, Body, and Spirit teleconference
The next Living Well With Myeloma Teleconference is Thursday, May 7, 2015. The subject is one that has been “in the news” and a hot topic in the medical world: Sustainable Wellness. Our Speaker for this topic is Dr. Matt Mumber and he has put together an excellent presentation that we feel will be beneficial to you and your group members.

In Loving Memory of Our Dear Friend Mike Katz, Long-Term IMF Board Member and Leading Patient Advocate
As you know, this past weekend the IMF lost a long-standing Board member and friend, Michael Katz. He routinely inspired patients to take charge of their myeloma and brought myeloma patient advocacy to the forefront. He was a colleague and friend to patients and physicians alike. IMF President Susie Novis recalls the many accomplishments and special spirit that made Mike a hero for myeloma patients everywhere. Read the story here. http://bit.ly/1OJVeCD

The International Myeloma Foundation Mourns the Passing of Board of Directors Member, Patient Champion, Michael S. Katz

This weekend the IMF lost a founding Board member who brought myeloma patient advocacy to the forefront. "Susie and I lost a dear and wonderful friend,” said IMF Chairman Dr. Brian Durie. “Mike Katz routinely inspired patients to take charge of their myeloma—to understand what is going on and get questions answered. He was a colleague and friend to patients and physicians alike. Mike, we will all miss you, we love you and will remember you always."


The Value of Annual PET/CT as a Screening Tool for Myeloma Patients
In last week’s blog, “How to Be Safer as You Live Longer,” IMF Chairman Brian Durie, MD cited the value of annual PET/CT as a screening tool to monitor low-level myeloma, detect hidden infection or an early second cancer. But what should a patient know when Medicare and supplemental insurance companies don’t cover the cost? In this week’s blog, Dr. Durie offers support for patients attempting to obtain reimbursement for these screenings. Click HERE to read.

Myeloma Patient Seminar in Italy Includes a Dash of Poetry
More than 100 people gathered in the town of Udine, Italy last week for a lively and informative myeloma patient event hosted by the Italian blood cancer patient group AIL. The organization is supported by a dedicated team of volunteers, according to IMF’s Director of Europe and the Middle East, Nadia Elkebir. Nadia delivered a well-received presentation about the IMF during the panel presentations in Udine and she reports on the many highlights of the event HERE.

Calling All Researchers: Submit Your Grant Applications for the 2016 Brian D. Novis Research Awards
The Brian D. Novis Research Awards honor the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance), as well as immunoglobulin derived amyloidosis. The 2016 awards are $50,000 each for junior grants and $80,000 for senior grants. August 3, 2015 is the deadline for applications. For more information and grant applications click HERE.

    next      view all